![Christian Lach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Lach
Corporate Officer/Principal chez
QUANTAFUEL
Profil
Christian Dietrich Lach is currently Chief Commercial Officer & Deputy CEO at Quantafuel AS since 2021.
Dr. Lach is also Director at Quantafuel Cheshire Ltd., Quantafuel Sunderland Ltd., and Quantafuel UK Ltd. since 2021.
Dr. Lach is Portfolio Manager at Konwave AG starting in 2025.
Formerly, Dr. Lach was Lead Portfolio Manager at Bellevue Asset Management AG from 2008 to 2025.
Dr. Lach was Senior Portfolio Manager & Research Analyst at Adamant Biomedical Investments AG from 2011 to 2014.
Dr. Lach earned a doctorate from the University of Freiburg.
Postes actifs de Christian Lach
| Sociétés | Poste | Début |
|---|---|---|
| QUANTAFUEL | Corporate Officer/Principal | 01/04/2021 |
Quantafuel Cheshire Ltd.
 Quantafuel Cheshire Ltd. Environmental ServicesIndustrial Services Engages in the treatment and disposal of non-hazardous waste | Directeur/Membre du Conseil | 21/09/2021 |
Quantafuel UK Ltd.
 Quantafuel UK Ltd. Other Metals/MineralsNon-Energy Minerals Operates as a chemical recycling company | Directeur/Membre du Conseil | 13/10/2021 |
Quantafuel Sunderland Ltd.
 Quantafuel Sunderland Ltd. Environmental ServicesIndustrial Services Provides treatment and disposal of non-hazardous waste services | Directeur/Membre du Conseil | 13/09/2021 |
Konwave AG
 Konwave AG Investment ManagersFinance Konwave seeks to generate for its clients added value relative to the benchmark, by investing into themes and companies, where the changes of success are the highest, taking into account the risks associated. The successful long-term cooperation with top geologists is instrumental for the stock picking within the small-caps. The firm utilizes both top-down/bottom-up investment process. The top-down approach does define the weights of the regions, the segments (major producer, intermediate producer, small producer, explorer und developer), the split between mining companies and physical metals (etfs, etcs) and the consolidated metal weight among the companies including physical metals (gold, silver, pgm’s and other metals). The bottom-up approach defines the stock selection and the weight of the individual companies in the portfolio. | Gestionnaire de Portefeuille-Actions | 01/07/2025 |
Anciens postes connus de Christian Lach
| Sociétés | Poste | Fin |
|---|---|---|
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue AM is an active, fundamental research-based manager which utilizes a bottom-up investment and anti-cyclical approach that aims to generate above-average returns while keeping risk under control and well monitored. They screen and invest in promising family and owner-managed companies based in Switzerland or the broader European continent through our family of Entrepreneur funds. The firm has become very adept at identifying high growth potential in new and emerging markets, particularly on the African continent. | Gestionnaire de Portefeuille-Actions | 01/05/2025 |
Adamant Biomedical Investments AG
 Adamant Biomedical Investments AG Investment ManagersFinance Adamant is a specialist investment manager investing in the biotechnology, medical technology and specialty pharmaceuticals sectors. Within these sectors, they invest in European and US equity. The firm's investment philosophy emphasizes fundamental research and leveraging an active network of scientists, doctors and financial experts to profit from the growth of the biomedical market. The firm manages their three portfolio sectors complementarily, the biotechnology sector providing opportunities for growth, medical technology offering sustainability, and specialty pharmaceuticals supplying stability. Demographics and medical breakthroughs are the major factors influencing Adamant's investment approach, as well as fundamental financial analysis at the company level. The management team includes experienced biomedical specialists with industry, research and asset management backgrounds. | Investor Relations Contact | - |
Formation de Christian Lach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue AM is an active, fundamental research-based manager which utilizes a bottom-up investment and anti-cyclical approach that aims to generate above-average returns while keeping risk under control and well monitored. They screen and invest in promising family and owner-managed companies based in Switzerland or the broader European continent through our family of Entrepreneur funds. The firm has become very adept at identifying high growth potential in new and emerging markets, particularly on the African continent. | Finance |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adamant Biomedical Investments AG
Adamant Biomedical Investments AG Investment ManagersFinance Adamant is a specialist investment manager investing in the biotechnology, medical technology and specialty pharmaceuticals sectors. Within these sectors, they invest in European and US equity. The firm's investment philosophy emphasizes fundamental research and leveraging an active network of scientists, doctors and financial experts to profit from the growth of the biomedical market. The firm manages their three portfolio sectors complementarily, the biotechnology sector providing opportunities for growth, medical technology offering sustainability, and specialty pharmaceuticals supplying stability. Demographics and medical breakthroughs are the major factors influencing Adamant's investment approach, as well as fundamental financial analysis at the company level. The management team includes experienced biomedical specialists with industry, research and asset management backgrounds. | Finance |
Konwave AG
Konwave AG Investment ManagersFinance Konwave seeks to generate for its clients added value relative to the benchmark, by investing into themes and companies, where the changes of success are the highest, taking into account the risks associated. The successful long-term cooperation with top geologists is instrumental for the stock picking within the small-caps. The firm utilizes both top-down/bottom-up investment process. The top-down approach does define the weights of the regions, the segments (major producer, intermediate producer, small producer, explorer und developer), the split between mining companies and physical metals (etfs, etcs) and the consolidated metal weight among the companies including physical metals (gold, silver, pgm’s and other metals). The bottom-up approach defines the stock selection and the weight of the individual companies in the portfolio. | Finance |
Quantafuel AS
 Quantafuel AS Environmental ServicesIndustrial Services Engages in recycling of plastic waste activities | Industrial Services |
Quantafuel Cheshire Ltd.
Quantafuel Cheshire Ltd. Environmental ServicesIndustrial Services Engages in the treatment and disposal of non-hazardous waste | Industrial Services |
Quantafuel Sunderland Ltd.
Quantafuel Sunderland Ltd. Environmental ServicesIndustrial Services Provides treatment and disposal of non-hazardous waste services | Industrial Services |
Quantafuel UK Ltd.
Quantafuel UK Ltd. Other Metals/MineralsNon-Energy Minerals Operates as a chemical recycling company | Non-Energy Minerals |
